Marcus‐Hillert Schultze‐Mosgau

Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative

Bernd Clement, Marcus‐Hillert Schultze‐Mosgau, Hanke Wohlers · Biochemical Pharmacology · 1993 · 65 citations

Urea Derivative, N-hydroxy-guanidine Metabolite, Biochemistry +8

Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women

Barbara Schütt, Andreas Kaiser, Marcus‐Hillert Schultze‐Mosgau et al. · Human Reproduction · 2016 · 43 citations · Full text

Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial

Marcus‐Hillert Schultze‐Mosgau, K. Waellnitz, R. Nave et al. · Human Reproduction · 2016 · 31 citations · Full text

Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential

Marcus‐Hillert Schultze‐Mosgau, Joachim Höchel, Olaf Prien et al. · Clinical Pharmacokinetics · 2018 · 29 citations · Full text

Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies

Carsten Möller, Wilhelm Bone, Arwed Cleve et al. · ChemMedChem · 2018 · 29 citations · Full text